Testes-specific protease 50 promotes cell invasion and metastasis by increasing NF-kappaB-dependent matrix metalloproteinase-9 expression

Cell Death and Disease

Volumn 6, Issue 3, 2015, Pages

  Song, Z B ^a   Ni, J S ^b   Wu, P ^a   Bao, Y L ^a   Liu, T ^b   Li, M ^b   Fan, C ^a   Zhang, W J ^a   Sun, L G ^a   Huang, Y X ^a   Li, Y X ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROGESTERONE RECEPTOR; SERINE PROTEINASE; TESTIS-SPECIFIC PROTEASE 50; TRANSCRIPTION FACTOR RELA;

ANIMAL; BIOSYNTHESIS; BREAST TUMOR; CANCER STAGING; CELL MOTION; DRUG SCREENING; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; METASTASIS; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; SURVIVAL; TESTIS; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; NF-KAPPA B; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TESTIS; TRANSCRIPTION FACTOR RELA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84965085447     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/CDDIS.2015.61     Document Type: Article

References (48)

1. Cavallaro U, Christofori G. Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim Biophys Acta 2001; 1552: 39–45.
2. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145–2154.
3. Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 1999; 43: S42–S51.
4. Ray JM, Stetler-Stevenson WG. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 1994; 7: 2062–2072.
5. Itoh Y, Nagase H. Matrix metalloproteinases in cancer. Essays Biochem 2002; 38: 21–36.
6. Chung TW, Moon SK, Lee YC, Kim JG, Ko JH, Kim CH. Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells. Arch Biochem Biophys 2002; 408: 147–154.
7. Basset P, Okada A, Chenard MP, Kannan R, Stoll I, Anglard P et al. Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications. Matrix Biol 1997; 15: 535–541.
8. Kohn EC, Liotta LA. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995; 55: 1856–1862.
9. Ura H, Bonfil RD, Reich R, Reddel R, Pfeifer A, Harris CC et al. Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res 1989; 49: 4615–4621.
10. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002; 295: 2387–2392.
11. Woo MS, Jung SH, Kim SY, Hyun JW, Ko KH, Kim WK et al. Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. Biochem Biophys Res Commun 2005; 335: 1017–1025.
12. Hong S, Park KK, Magae J, Ando K, Lee TS, Kwon TK et al. Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells. J Biol Chem 2005; 280: 25202–25209.
13. Nabeshima K, Inoue T, Shimao Y, Sameshima T. Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int 2002; 52: 255–264.
14. Stetler-Stevenson WG, Hewitt R, Corcoran M. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol 1996; 7: 147–154.
15. Mendis E, Kim MM, Rajapakse N, Kim SK. The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions. Bioorg Med Chem Lett 2009; 19: 2755–2759.
16. Connelly L, Robinson-Benion C, Chont M, Saint-Jean L, Li H, Polosukhin VV et al. A transgenic model reveals important roles for the NF-kappa B alternative pathway (p100/p52) in mammary development and links to tumorigenesis. J Biol Chem 2007; 282: 10028–10035.
17. Shan J, Yuan L, Xiao Q, Chiorazzi N, Budman D, Teichberg S et al. TSP50, a possible protease in human testes, is activated in breast cancer epithelial cells. Cancer Res 2002; 62: 290–294.
18. Yuan L, Shan J, De Risi D, Broome J, Lovecchio J, Gal D et al. Isolation of a novel gene, TSP50, by a hypomethylated DNA fragment in human breast cancer. Cancer Res 1999; 59: 3215–3221.
19. Zheng L, Xie G, Duan G, Yan X, Li Q. High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma. PLoS One 2011; 6: e22203.
20. Zhou L, Bao YL, Zhang Y, Wu Y, Yu CL, Huang YX et al. Knockdown of TSP50 inhibits cell proliferation and induces apoptosis in P19 cells. IUBMB Life 2010; 62: 825–832.
21. Mi XG, Song ZB, Wu P, Zhang YW, Sun LG, Bao YL et al. Alantolactone induces cell apoptosis partially through down-regulation of testes-specific protease 50 expression. Toxicol Lett 2014; 224: 349–355.
22. Song ZB, Bao YL, Zhang Y, Mi XG, Wu P, Wu Y et al. Testes-specific protease 50 (TSP50) promotes cell proliferation through the activation of the nuclear factor kappaB (NF-kappaB) signalling pathway. Biochem J 2011; 436: 457–467.
23. Li YY, Bao YL, Song ZB, Sun LG, Wu P, Zhang Y et al. The threonine protease activity of testes-specific protease 50 (TSP50) is essential for its function in cell proliferation. PLoS One 2012; 7: e35030.
24. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 2007; 109: 1721–1728.
25. Perera NM, Gui GP. Multi-ethnic differences in breast cancer: current concepts and future directions. Int J Cancer 2003; 106: 463–467.
26. Merrill RM, Weed DL. Measuring the public health burden of cancer in the United States through lifetime and age-conditional risk estimates. Ann Epidemiol 2001; 11: 547–553.
27. Edelman DB, Keefer EW. A cultural renaissance: in vitro cell biology embraces three-dimensional context. Exp Neurol 2005; 192: 1–6.
28. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003; 114: 33–45.
29. Cukierman E, Pankov R, Stevens DR, Yamada KM. Taking cell-matrix adhesions to the third dimension. Science 2001; 294: 1708–1712.
30. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563–572.
31. Luo BH, Carman CV, Springer TA. Structural basis of integrin regulation and signaling. Annu Rev Immunol 2007; 25: 619–647.
32. Bogenrieder T, Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 2003; 22: 6524–6536.
33. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet Jr RJ, Sledge GW Jr. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 1997; 17: 3629–3639.
34. Sung B, Pandey MK, Ahn KS, Yi T, Chaturvedi MM, Liu M et al. Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis. Blood 2008; 111: 4880–4891.
35. Pandey MK, Sung B, Kunnumakkara AB, Sethi G, Chaturvedi MM, Aggarwal BB. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res 2008; 68: 5370–5379.
36. Rhode J, Fogoros S, Zick S, Wahl H, Griffith KA, Huang J et al. Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC Complement Altern Med 2007; 7: 44.
37. Chang HJ, Kim MH, Baek MK, Park JS, Chung IJ, Shin BA et al. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells. Anticancer Res 2007; 27: 3411–3417.
38. Sharma C, Kaur J, Shishodia S, Aggarwal BB, Ralhan R. Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology 2006; 228: 1–15.
39. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000; 18: 1135–1149.
40. Kim JH, Lee KW, Lee MW, Lee HJ, Kim SH, Surh YJ. Hirsutenone inhibits phorbol ester-induced upregulation of COX-2 and MMP-9 in cultured human mammary epithelial cells: NF-kappaB as a potential molecular target. FEBS Lett 2006; 580: 385–392.
41. Wu TT, Tsai JH, Kuo SJ, Yu SY, Huang CY, Hsieh HY et al. Augmented release of matrix metalloproteinase-9 by PKC activation in organotypic cultures of human breast cancer and adjacent normal breast tissue and fibroadenoma. Chin J Physiol 2004; 47: 73–78.
42. Huang Q, Shen HM, Ong CN. Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB. Biochem Pharmacol 2004; 68: 361–371.
43. Liu JF, Crepin M, Liu JM, Barritault D, Ledoux D. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem Biophys Res Commun 2002; 293: 1174–1182.
44. Zhang Y, Zhou L, Bao YL, Wu Y, Yu CL, Huang YX et al. Butyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells. Chem Biol Interact 2010; 185: 174–181.
45. Lee EJ, Kim SY, Hyun JW, Min SW, Kim DH, Kim HS. Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression. Chem Biol Interact 2010; 185: 18–24.
46. Yodkeeree S, Ampasavate C, Sung B, Aggarwal BB, Limtrakul P. Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line. Eur J Pharmacol 2009; 627: 8–15.
47. Frisk T, Rydholm S, Liebmann T, Svahn HA, Stemme G, Brismar H. A microfluidic device for parallel 3-D cell cultures in asymmetric environments. Electrophoresis 2007; 28: 4705–4712.
48. Wang X, Lu H, Urvalek AM, Li T, Yu L, Lamar J et al. KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9. Oncogene 2011; 30: 1901–1911.